UXIN LTD - ADR (UXIN)

US91818X3061 - ADR

4.03  +0.25 (+6.61%)

Fundamental Rating

1

UXIN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 122 industry peers in the Specialty Retail industry. UXIN may be in some trouble as it scores bad on both profitability and health. UXIN is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

UXIN had negative earnings in the past year.
UXIN had negative earnings in each of the past 5 years.
UXIN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

UXIN has a Return On Assets of -58.75%. This is amonst the worse of the industry: UXIN underperforms 93.39% of its industry peers.
Industry RankSector Rank
ROA -58.75%
ROE N/A
ROIC N/A
ROA(3y)-56.61%
ROA(5y)-47.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

UXIN has a worse Gross Margin (3.45%) than 95.87% of its industry peers.
UXIN's Gross Margin has declined in the last couple of years.
UXIN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-72.05%
GM growth 5Y-54.25%

0

2. Health

2.1 Basic Checks

UXIN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, UXIN has more shares outstanding
The number of shares outstanding for UXIN has been increased compared to 5 years ago.
Compared to 1 year ago, UXIN has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -9.24, we must say that UXIN is in the distress zone and has some risk of bankruptcy.
UXIN's Altman-Z score of -9.24 is on the low side compared to the rest of the industry. UXIN is outperformed by 92.56% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -9.24
ROIC/WACCN/A
WACC7.97%

2.3 Liquidity

A Current Ratio of 0.39 indicates that UXIN may have some problems paying its short term obligations.
UXIN has a Current ratio of 0.39. This is amonst the worse of the industry: UXIN underperforms 95.87% of its industry peers.
UXIN has a Quick Ratio of 0.39. This is a bad value and indicates that UXIN is not financially healthy enough and could expect problems in meeting its short term obligations.
UXIN has a worse Quick ratio (0.14) than 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.14

6

3. Growth

3.1 Past

UXIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 67.96%, which is quite impressive.
Looking at the last year, UXIN shows a very strong growth in Revenue. The Revenue has grown by 148.87%.
The Revenue has been growing by 14.69% on average over the past years. This is quite good.
EPS 1Y (TTM)67.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.93%
Revenue 1Y (TTM)148.87%
Revenue growth 3Y35.4%
Revenue growth 5Y14.69%
Sales Q2Q%44.16%

3.2 Future

Based on estimates for the next years, UXIN will show a very negative growth in Earnings Per Share. The EPS will decrease by -22.81% on average per year.
Based on estimates for the next years, UXIN will show a very strong growth in Revenue. The Revenue will grow by 87.81% on average per year.
EPS Next Y-4475.5%
EPS Next 2Y-66.69%
EPS Next 3Y-22.81%
EPS Next 5YN/A
Revenue Next Year53.35%
Revenue Next 2Y137.9%
Revenue Next 3Y87.81%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

UXIN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for UXIN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as UXIN's earnings are expected to decrease with -22.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-66.69%
EPS Next 3Y-22.81%

0

5. Dividend

5.1 Amount

UXIN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UXIN LTD - ADR

NASDAQ:UXIN (12/20/2024, 8:00:01 PM)

4.03

+0.25 (+6.61%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-25 2024-11-25/bmo
Earnings (Next)N/A N/A
Inst Owners0.19%
Inst Owner Change71.37%
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap757.43M
Analysts43.33
Price TargetN/A
Short Float %0.28%
Short Ratio2.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-54.88%
Min Revenue beat(2)-58.49%
Max Revenue beat(2)-51.27%
Revenue beat(4)0
Avg Revenue beat(4)-34.85%
Min Revenue beat(4)-58.49%
Max Revenue beat(4)-0.49%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.79
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.06
BVpS-0.14
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -58.75%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.45%
FCFM N/A
ROA(3y)-56.61%
ROA(5y)-47.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-72.05%
GM growth 5Y-54.25%
F-ScoreN/A
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.39
Quick Ratio 0.14
Altman-Z -9.24
F-ScoreN/A
WACC7.97%
ROIC/WACCN/A
Cap/Depr(3y)57.08%
Cap/Depr(5y)72.38%
Cap/Sales(3y)0.94%
Cap/Sales(5y)5.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.93%
EPS Next Y-4475.5%
EPS Next 2Y-66.69%
EPS Next 3Y-22.81%
EPS Next 5YN/A
Revenue 1Y (TTM)148.87%
Revenue growth 3Y35.4%
Revenue growth 5Y14.69%
Sales Q2Q%44.16%
Revenue Next Year53.35%
Revenue Next 2Y137.9%
Revenue Next 3Y87.81%
Revenue Next 5YN/A
EBIT growth 1Y26.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.45%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y67.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.28%
OCF growth 3YN/A
OCF growth 5YN/A